Operating Lease, Liability, Noncurrent of REGENERON PHARMACEUTICALS, INC. from 31 Mar 2019 to 31 Dec 2024

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Summary: REGENERON PHARMACEUTICALS, INC. quarterly Operating Lease, Liability, Noncurrent in USD history and change rate from 31 Mar 2019 to 31 Dec 2024.
REGENERON PHARMACEUTICALS, INC. Operating Lease, Liability, Noncurrent for the quarter ending 31 Dec 2024 was $204,100,000, a 197% increase year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Liability, Noncurrent, Quarterly (USD)

Operating Lease, Liability, Noncurrent, YoY Quarterly Change (%)

REGENERON PHARMACEUTICALS, INC. Quarterly Operating Lease, Liability, Noncurrent (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	$204,100,000	+$135,400,000	+197%	31 Dec 2024	10-K	05 Feb 2025	2024	FY
Q4 2023	$68,700,000	+$12,900,000	+23%	31 Dec 2023	10-K	05 Feb 2025	2024	FY
Q4 2022	$55,800,000			31 Dec 2022	10-K	05 Feb 2024	2023	FY
Q3 2019	$25,300,000			30 Sep 2019	10-Q	05 Nov 2019	2019	Q3
Q2 2019	$27,700,000			30 Jun 2019	10-Q	06 Aug 2019	2019	Q2
Q1 2019	$29,400,000			31 Mar 2019	10-Q	07 May 2019	2019	Q1

* An asterisk sign (*) next to the value indicates that the value is likely invalid.